These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7214720)

  • 1. The cardiovascular effect of vasopressin in relation to its plasma concentration in man and its relevance to high blood pressure.
    Khokhar AM; Slater JD; Ma J; Ramage CM
    Clin Endocrinol (Oxf); 1980 Sep; 13(3):259-66. PubMed ID: 7214720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A radioimmunoassay for plasma arginine-vasopressin in man and dog: application to physiological and pathological states.
    Morton JJ; Padfield PL; Forsling ML
    J Endocrinol; 1975 Jun; 65(3):411-24. PubMed ID: 168297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular effects of arginine vasopressin during fluid deprivation in the rat.
    Aisenbrey GA; Handelman WA; Arnold P; Manning M; Schrier RW
    J Clin Invest; 1981 Apr; 67(4):961-8. PubMed ID: 7204578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmatic arginine vasopressin levels in total and partial diabetes insipidus.
    Sanmartí A; Galard R; Catalàn R; Foz M; Castellanos JM
    J Endocrinol Invest; 1985 Apr; 8(2):127-30. PubMed ID: 4031379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal and cardiovascular responses to DDAVP in man.
    Williams TD; Lightman SL; Leadbeater MJ
    Clin Endocrinol (Oxf); 1986 Jan; 24(1):89-96. PubMed ID: 3519005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic and humoral consequences of chronic infusion of vasopressin in conscious rats.
    Tsuchihashi T; Takata Y; Nakao Y; Tominaga M; Takishita S; Kobayashi K; Abe I; Fujishima M
    Clin Exp Pharmacol Physiol; 1993; 20(7-8):489-95. PubMed ID: 8403529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the vascular effect of vasopressin in patients with mild essential hypertension.
    Bussien JP; Waeber B; Nussberger J; Hofbauer KG; Brunner HR
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):130-9. PubMed ID: 3767522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heterologous radioimmunoassay for arginine vasopressin.
    Shimamoto K; Murase T; Yamaji T
    J Lab Clin Med; 1976 Feb; 87(2):338-44. PubMed ID: 1245796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma vasopressin and human neurophysins in physiological and pathological states associated with changes in vasopressin secretion.
    Pullan PT; Clappison BH; Johnston CI
    J Clin Endocrinol Metab; 1979 Oct; 49(4):580-7. PubMed ID: 479348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin dose-response effects on fetal vascular pressures, heart rate, and blood volume.
    Tomita H; Brace RA; Cheung CY; Longo LD
    Am J Physiol; 1985 Nov; 249(5 Pt 2):H974-80. PubMed ID: 3933366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of transient cranial diabetes insipidus during pregnancy.
    Williams DJ; Metcalfe KA; Skingle L; Stock AI; Beedham T; Monson JP
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):595-600. PubMed ID: 8334746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of arginine vasopressin and arterial blood pressure in a population-based sample.
    Zhang X; Hense HW; Riegger GA; Schunkert H
    J Hypertens; 1999 Mar; 17(3):319-24. PubMed ID: 10100068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of AVP and DDAVP on plasma renin activity and electrolyte excretion in conscious dogs.
    Johnson MD; Kinter LB; Beeuwkes R
    Am J Physiol; 1979 Jan; 236(1):F66-70. PubMed ID: 434155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovine fetal response to water deprivation: aspects on the role of vasopressin.
    Herin P; Kim JK; Schrier RW; Meschia G; Battaglia FC
    Q J Exp Physiol; 1988 Nov; 73(6):931-40. PubMed ID: 3148961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of administration of corticotropin-releasing hormone and glucocorticoid on arginine vasopressin response to osmotic stimulus in normal subjects and patients with hypocorticotropinism without overt diabetes insipidus.
    Yamada K; Tamura Y; Yoshida S
    J Clin Endocrinol Metab; 1989 Aug; 69(2):396-401. PubMed ID: 2546964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of centrally administered ET-1-induced increases in systemic arterial pressure and AVP secretion.
    Rossi NF; O'Leary DS; Chen H
    Am J Physiol; 1997 Jan; 272(1 Pt 1):E126-32. PubMed ID: 9038861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and arginine vasopressin (AVP) responses to haemorrhage and nitroprusside infusion in conscious newborn calves.
    Giry J; Kati-Coulibaly S; Barlet JP
    Arch Int Physiol Biochim Biophys; 1991 Apr; 99(2):169-74. PubMed ID: 1713502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vasopressin on cardiovascular and renal functions and ANP release under plasma volume expansion.
    Ohta M; Kimura T; Ota K; Shoji M; Inoue M; Sato K; Yamamoto T; Yoshinaga K
    Tohoku J Exp Med; 1991 Oct; 165(2):115-29. PubMed ID: 1839872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma.
    Robertson GL; Mahr EA; Athar S; Sinha T
    J Clin Invest; 1973 Sep; 52(9):2340-52. PubMed ID: 4727463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pressor responsiveness and cardiovascular reflex activity in spontaneously hypertensive and normotensive rates during vasopressin infusion.
    Möhring J; Kintz J; Schoun J; McNeill JR
    J Cardiovasc Pharmacol; 1981; 3(5):948-57. PubMed ID: 6168862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.